Corrigendum to 'Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial' [Eur J Canc 124 (January 2020) 25-36]
1 Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: [email protected].
2 Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
3 Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
4 Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
5 Center for Clinical Trials, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
6 Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.